Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 112 | 2024 | 785 | 19.830 |
Why?
|
Diet, Gluten-Free | 60 | 2023 | 271 | 9.280 |
Why?
|
Glutens | 32 | 2021 | 230 | 5.960 |
Why?
|
Colonoscopy | 17 | 2019 | 1367 | 2.600 |
Why?
|
Transglutaminases | 19 | 2021 | 194 | 2.110 |
Why?
|
Serologic Tests | 10 | 2019 | 374 | 1.790 |
Why?
|
Gastroenterology | 15 | 2022 | 538 | 1.710 |
Why?
|
Enterocolitis, Pseudomembranous | 7 | 2015 | 264 | 1.480 |
Why?
|
Gastrointestinal Agents | 6 | 2019 | 494 | 1.390 |
Why?
|
Patient Compliance | 16 | 2022 | 2685 | 1.320 |
Why?
|
Gliadin | 13 | 2021 | 79 | 1.220 |
Why?
|
Conscious Sedation | 3 | 2016 | 528 | 1.140 |
Why?
|
Endoscopy, Gastrointestinal | 13 | 2020 | 868 | 1.120 |
Why?
|
Clostridium Infections | 7 | 2017 | 548 | 1.060 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2016 | 1131 | 1.050 |
Why?
|
Duodenum | 11 | 2023 | 484 | 1.010 |
Why?
|
Adenoma | 8 | 2018 | 2174 | 0.970 |
Why?
|
Methemoglobinemia | 2 | 2013 | 44 | 0.910 |
Why?
|
Oligopeptides | 6 | 2018 | 1189 | 0.910 |
Why?
|
Immunoglobulin A | 16 | 2023 | 995 | 0.900 |
Why?
|
Autoantibodies | 15 | 2023 | 2036 | 0.900 |
Why?
|
Intestinal Mucosa | 14 | 2023 | 3037 | 0.880 |
Why?
|
Cost of Illness | 6 | 2020 | 1860 | 0.860 |
Why?
|
Gastric Juice | 1 | 2021 | 63 | 0.790 |
Why?
|
Anesthesia, Local | 2 | 2013 | 275 | 0.780 |
Why?
|
HLA-DQ Antigens | 6 | 2020 | 210 | 0.720 |
Why?
|
Capsule Endoscopy | 2 | 2023 | 125 | 0.710 |
Why?
|
Food Hypersensitivity | 5 | 2021 | 622 | 0.710 |
Why?
|
Endopeptidases | 2 | 2021 | 772 | 0.700 |
Why?
|
Colonic Polyps | 4 | 2019 | 542 | 0.650 |
Why?
|
Biopsy | 19 | 2024 | 6755 | 0.640 |
Why?
|
Antidotes | 2 | 2016 | 138 | 0.630 |
Why?
|
Humans | 194 | 2024 | 744376 | 0.620 |
Why?
|
Irritable Bowel Syndrome | 6 | 2017 | 445 | 0.620 |
Why?
|
Drug Evaluation | 2 | 2016 | 647 | 0.600 |
Why?
|
Midazolam | 2 | 2016 | 270 | 0.600 |
Why?
|
GTP-Binding Proteins | 9 | 2020 | 970 | 0.570 |
Why?
|
Gastrointestinal Diseases | 6 | 2017 | 1170 | 0.560 |
Why?
|
Anesthetics, Local | 2 | 2013 | 985 | 0.560 |
Why?
|
Anti-Bacterial Agents | 10 | 2018 | 7182 | 0.560 |
Why?
|
Fentanyl | 2 | 2016 | 409 | 0.550 |
Why?
|
Hypersensitivity | 2 | 2015 | 1102 | 0.550 |
Why?
|
Mesalamine | 2 | 2014 | 136 | 0.550 |
Why?
|
Colorectal Neoplasms | 8 | 2019 | 6773 | 0.550 |
Why?
|
Health Status | 4 | 2020 | 4033 | 0.530 |
Why?
|
Male | 111 | 2024 | 350118 | 0.520 |
Why?
|
Capnography | 1 | 2016 | 89 | 0.520 |
Why?
|
Diarrhea | 6 | 2022 | 1348 | 0.510 |
Why?
|
Middle Aged | 85 | 2023 | 213388 | 0.510 |
Why?
|
Female | 113 | 2022 | 380200 | 0.510 |
Why?
|
Anti-Inflammatory Agents | 4 | 2020 | 1790 | 0.500 |
Why?
|
Colonic Diseases | 1 | 2016 | 202 | 0.480 |
Why?
|
Health Resources | 1 | 2020 | 911 | 0.480 |
Why?
|
Adult | 83 | 2023 | 214056 | 0.480 |
Why?
|
Radionuclide Imaging | 2 | 2016 | 2031 | 0.470 |
Why?
|
Eosinophils | 2 | 2018 | 955 | 0.470 |
Why?
|
Colitis, Ulcerative | 4 | 2020 | 1911 | 0.470 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 418 | 0.470 |
Why?
|
Triticum | 2 | 2012 | 86 | 0.470 |
Why?
|
Osteoporosis | 3 | 2022 | 1579 | 0.460 |
Why?
|
Eosinophilia | 1 | 2018 | 541 | 0.460 |
Why?
|
Hypnotics and Sedatives | 3 | 2016 | 1162 | 0.450 |
Why?
|
Deep Sedation | 1 | 2014 | 121 | 0.450 |
Why?
|
Budesonide | 4 | 2020 | 154 | 0.440 |
Why?
|
Alanine Transaminase | 1 | 2015 | 592 | 0.430 |
Why?
|
Ambulatory Care | 3 | 2020 | 2708 | 0.430 |
Why?
|
Inflammatory Bowel Diseases | 9 | 2022 | 2428 | 0.420 |
Why?
|
Severity of Illness Index | 13 | 2020 | 15535 | 0.400 |
Why?
|
Probiotics | 3 | 2016 | 351 | 0.400 |
Why?
|
Hospitalization | 6 | 2020 | 10259 | 0.390 |
Why?
|
Narcotic Antagonists | 1 | 2016 | 562 | 0.390 |
Why?
|
Emergency Service, Hospital | 6 | 2020 | 7658 | 0.390 |
Why?
|
Quality Improvement | 4 | 2019 | 3749 | 0.390 |
Why?
|
Congresses as Topic | 1 | 2015 | 764 | 0.380 |
Why?
|
Withholding Treatment | 1 | 2014 | 599 | 0.370 |
Why?
|
Health Care Costs | 2 | 2020 | 3209 | 0.360 |
Why?
|
Morbidity | 1 | 2015 | 1768 | 0.360 |
Why?
|
Education, Medical, Undergraduate | 5 | 2017 | 1008 | 0.360 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 2282 | 0.360 |
Why?
|
Guideline Adherence | 6 | 2016 | 2265 | 0.360 |
Why?
|
Drug Approval | 1 | 2016 | 742 | 0.350 |
Why?
|
Food Services | 1 | 2012 | 192 | 0.350 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 935 | 0.330 |
Why?
|
Autoimmunity | 1 | 2016 | 1350 | 0.330 |
Why?
|
Quality of Life | 7 | 2021 | 12803 | 0.330 |
Why?
|
Drug Discovery | 2 | 2016 | 1058 | 0.330 |
Why?
|
Abdominal Pain | 2 | 2019 | 1064 | 0.330 |
Why?
|
Practice Guidelines as Topic | 9 | 2016 | 7281 | 0.320 |
Why?
|
Aged | 56 | 2024 | 163284 | 0.320 |
Why?
|
Young Adult | 34 | 2020 | 56434 | 0.300 |
Why?
|
Reminder Systems | 1 | 2011 | 371 | 0.300 |
Why?
|
Perception | 1 | 2014 | 1198 | 0.300 |
Why?
|
Gastroesophageal Reflux | 2 | 2014 | 782 | 0.300 |
Why?
|
Teaching | 3 | 2017 | 1174 | 0.300 |
Why?
|
Medical Records | 5 | 2017 | 1413 | 0.300 |
Why?
|
Universities | 1 | 2012 | 956 | 0.290 |
Why?
|
Gastroparesis | 1 | 2009 | 131 | 0.290 |
Why?
|
Gastric Emptying | 1 | 2009 | 233 | 0.290 |
Why?
|
Aged, 80 and over | 27 | 2019 | 57776 | 0.280 |
Why?
|
Case-Control Studies | 12 | 2024 | 21747 | 0.280 |
Why?
|
Colitis, Microscopic | 1 | 2007 | 77 | 0.270 |
Why?
|
Salivary Proline-Rich Proteins | 2 | 2015 | 5 | 0.270 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7785 | 0.270 |
Why?
|
Quality Indicators, Health Care | 4 | 2018 | 1831 | 0.270 |
Why?
|
Testosterone | 1 | 2016 | 2419 | 0.260 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3395 | 0.260 |
Why?
|
Risk Factors | 25 | 2020 | 72295 | 0.260 |
Why?
|
Nutritional Status | 1 | 2014 | 1609 | 0.260 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1239 | 0.260 |
Why?
|
Mortality | 2 | 2019 | 2864 | 0.260 |
Why?
|
Retrospective Studies | 28 | 2023 | 77459 | 0.260 |
Why?
|
Genetic Testing | 2 | 2015 | 3444 | 0.250 |
Why?
|
Anemia | 3 | 2022 | 1503 | 0.250 |
Why?
|
Amoxicillin | 2 | 2016 | 170 | 0.250 |
Why?
|
Atrophy | 7 | 2023 | 1584 | 0.240 |
Why?
|
Esophageal Diseases | 2 | 2015 | 167 | 0.240 |
Why?
|
Feces | 5 | 2020 | 1401 | 0.240 |
Why?
|
Treatment Outcome | 17 | 2020 | 63115 | 0.240 |
Why?
|
Conflict of Interest | 5 | 2016 | 544 | 0.240 |
Why?
|
Predictive Value of Tests | 13 | 2018 | 15078 | 0.240 |
Why?
|
Proton Pump Inhibitors | 3 | 2017 | 526 | 0.240 |
Why?
|
Hospital Costs | 1 | 2010 | 985 | 0.240 |
Why?
|
Colonic Neoplasms | 2 | 2018 | 2542 | 0.240 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 990 | 0.230 |
Why?
|
Focus Groups | 3 | 2014 | 1321 | 0.230 |
Why?
|
Research Support as Topic | 3 | 2021 | 705 | 0.230 |
Why?
|
Evidence-Based Medicine | 5 | 2016 | 3610 | 0.220 |
Why?
|
Cross Infection | 3 | 2017 | 1417 | 0.220 |
Why?
|
Bronchial Diseases | 2 | 2014 | 151 | 0.220 |
Why?
|
Informed Consent | 2 | 2019 | 995 | 0.220 |
Why?
|
Outpatients | 1 | 2010 | 1487 | 0.220 |
Why?
|
Medication Adherence | 1 | 2014 | 2063 | 0.220 |
Why?
|
Follow-Up Studies | 13 | 2023 | 39052 | 0.210 |
Why?
|
Time Factors | 13 | 2018 | 40077 | 0.210 |
Why?
|
Pulmonary Medicine | 2 | 2014 | 213 | 0.200 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2375 | 0.200 |
Why?
|
Fellowships and Scholarships | 3 | 2019 | 1078 | 0.200 |
Why?
|
Endoscopy, Digestive System | 2 | 2015 | 345 | 0.200 |
Why?
|
Random Allocation | 2 | 2021 | 2428 | 0.200 |
Why?
|
Histamine H2 Antagonists | 2 | 2017 | 165 | 0.200 |
Why?
|
Data Collection | 2 | 2017 | 3339 | 0.190 |
Why?
|
Dietetics | 1 | 2020 | 35 | 0.190 |
Why?
|
Women's Health | 1 | 2010 | 2034 | 0.190 |
Why?
|
Cost-Benefit Analysis | 5 | 2020 | 5390 | 0.190 |
Why?
|
Education, Medical, Continuing | 3 | 2015 | 840 | 0.190 |
Why?
|
Career Choice | 1 | 2017 | 744 | 0.190 |
Why?
|
Early Detection of Cancer | 4 | 2019 | 3086 | 0.180 |
Why?
|
Anticoagulants | 2 | 2015 | 4600 | 0.180 |
Why?
|
Quality of Health Care | 1 | 2015 | 4369 | 0.180 |
Why?
|
Nephrology | 2 | 2014 | 263 | 0.180 |
Why?
|
Norway | 1 | 2021 | 448 | 0.180 |
Why?
|
Immunologic Tests | 1 | 2020 | 103 | 0.180 |
Why?
|
Documentation | 2 | 2017 | 871 | 0.180 |
Why?
|
Recurrence | 7 | 2019 | 8340 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3873 | 0.180 |
Why?
|
Staff Development | 2 | 2015 | 223 | 0.180 |
Why?
|
Prospective Studies | 18 | 2023 | 53291 | 0.170 |
Why?
|
Autoimmune Diseases | 3 | 2024 | 2133 | 0.170 |
Why?
|
Massachusetts | 5 | 2016 | 8662 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2016 | 1660 | 0.170 |
Why?
|
Forecasting | 1 | 2008 | 2951 | 0.160 |
Why?
|
Tropheryma | 1 | 2018 | 3 | 0.160 |
Why?
|
Diagnostic Techniques, Digestive System | 2 | 2016 | 47 | 0.160 |
Why?
|
Cohort Studies | 13 | 2020 | 40558 | 0.160 |
Why?
|
Whipple Disease | 1 | 2018 | 19 | 0.160 |
Why?
|
Gastrointestinal Tract | 3 | 2016 | 814 | 0.160 |
Why?
|
Body Mass Index | 2 | 2016 | 12720 | 0.160 |
Why?
|
Antibodies | 3 | 2017 | 2460 | 0.160 |
Why?
|
Physicians | 4 | 2018 | 4567 | 0.160 |
Why?
|
Interviews as Topic | 2 | 2017 | 2539 | 0.150 |
Why?
|
United States | 15 | 2021 | 69869 | 0.150 |
Why?
|
o-Phthalaldehyde | 1 | 2017 | 16 | 0.150 |
Why?
|
Ethylene Oxide | 1 | 2017 | 27 | 0.150 |
Why?
|
Duodenoscopy | 1 | 2017 | 52 | 0.150 |
Why?
|
Diet Therapy | 1 | 2018 | 154 | 0.150 |
Why?
|
Immunoglobulin G | 6 | 2017 | 4561 | 0.150 |
Why?
|
Equipment Reuse | 1 | 2017 | 41 | 0.150 |
Why?
|
Age Factors | 5 | 2019 | 18373 | 0.150 |
Why?
|
Clavulanic Acid | 1 | 2016 | 19 | 0.150 |
Why?
|
Duodenoscopes | 1 | 2017 | 44 | 0.150 |
Why?
|
Protein Engineering | 1 | 2021 | 538 | 0.150 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2278 | 0.150 |
Why?
|
Critical Illness | 1 | 2010 | 2670 | 0.150 |
Why?
|
Double-Blind Method | 6 | 2021 | 12025 | 0.140 |
Why?
|
Ataxia | 1 | 2019 | 304 | 0.140 |
Why?
|
Patient Care | 2 | 2013 | 640 | 0.140 |
Why?
|
Sterilization | 1 | 2017 | 133 | 0.140 |
Why?
|
Prevalence | 9 | 2020 | 15221 | 0.140 |
Why?
|
Clinical Competence | 3 | 2017 | 4687 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1381 | 0.140 |
Why?
|
Feeding Behavior | 1 | 2009 | 3188 | 0.140 |
Why?
|
Dyspepsia | 1 | 2017 | 116 | 0.140 |
Why?
|
Flumazenil | 1 | 2016 | 84 | 0.140 |
Why?
|
Tight Junctions | 3 | 2015 | 311 | 0.140 |
Why?
|
Income | 2 | 2016 | 1913 | 0.140 |
Why?
|
IgA Deficiency | 1 | 2016 | 43 | 0.140 |
Why?
|
Disinfectants | 1 | 2017 | 116 | 0.140 |
Why?
|
Equipment Contamination | 1 | 2017 | 185 | 0.140 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 412 | 0.140 |
Why?
|
Lactobacillus | 1 | 2017 | 189 | 0.140 |
Why?
|
Lactulose | 2 | 2012 | 33 | 0.130 |
Why?
|
Enterotoxins | 2 | 2015 | 368 | 0.130 |
Why?
|
Adolescent | 20 | 2019 | 85784 | 0.130 |
Why?
|
Atropine | 1 | 2016 | 244 | 0.130 |
Why?
|
Metronidazole | 1 | 2016 | 217 | 0.130 |
Why?
|
Logistic Models | 8 | 2024 | 13409 | 0.130 |
Why?
|
Iohexol | 1 | 2016 | 196 | 0.130 |
Why?
|
North America | 2 | 2019 | 1249 | 0.130 |
Why?
|
Intestine, Large | 1 | 2015 | 71 | 0.130 |
Why?
|
Disinfection | 1 | 2017 | 191 | 0.130 |
Why?
|
Salivary Proteins and Peptides | 1 | 2015 | 53 | 0.130 |
Why?
|
Citrulline | 1 | 2015 | 105 | 0.130 |
Why?
|
Biomedical Research | 3 | 2021 | 3309 | 0.130 |
Why?
|
Trametes | 1 | 2014 | 2 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8642 | 0.130 |
Why?
|
Health Surveys | 2 | 2016 | 4036 | 0.130 |
Why?
|
Personality | 1 | 2018 | 552 | 0.130 |
Why?
|
Injections | 1 | 2018 | 840 | 0.130 |
Why?
|
Off-Label Use | 1 | 2016 | 169 | 0.120 |
Why?
|
Malnutrition | 2 | 2012 | 625 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3508 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3338 | 0.120 |
Why?
|
Gastric Acid | 1 | 2014 | 104 | 0.120 |
Why?
|
Vancomycin Resistance | 1 | 2015 | 128 | 0.120 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2291 | 0.120 |
Why?
|
beta-Alanine | 1 | 2014 | 74 | 0.120 |
Why?
|
Prebiotics | 1 | 2014 | 44 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 518 | 0.120 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2016 | 300 | 0.120 |
Why?
|
Sex Factors | 3 | 2016 | 10400 | 0.120 |
Why?
|
Stomach Diseases | 1 | 2015 | 134 | 0.120 |
Why?
|
Bradycardia | 1 | 2016 | 307 | 0.120 |
Why?
|
Crohn Disease | 2 | 2020 | 2304 | 0.120 |
Why?
|
Salicylates | 1 | 2014 | 126 | 0.120 |
Why?
|
Risk Assessment | 8 | 2019 | 23336 | 0.120 |
Why?
|
Sensitivity and Specificity | 9 | 2019 | 14723 | 0.120 |
Why?
|
Decision Support Techniques | 2 | 2014 | 1956 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2015 | 528 | 0.120 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 780 | 0.120 |
Why?
|
Acute Disease | 2 | 2016 | 7147 | 0.120 |
Why?
|
Benzocaine | 1 | 2013 | 15 | 0.120 |
Why?
|
Esophageal Stenosis | 1 | 2015 | 195 | 0.110 |
Why?
|
Fertility | 2 | 2010 | 781 | 0.110 |
Why?
|
Naloxone | 1 | 2016 | 367 | 0.110 |
Why?
|
Lymphocytosis | 1 | 2014 | 119 | 0.110 |
Why?
|
Vancomycin | 1 | 2016 | 501 | 0.110 |
Why?
|
Students, Dental | 1 | 2015 | 160 | 0.110 |
Why?
|
Trypsin Inhibitors | 1 | 2012 | 36 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2015 | 1181 | 0.110 |
Why?
|
Folic Acid Deficiency | 1 | 2014 | 115 | 0.110 |
Why?
|
Group Processes | 2 | 2012 | 225 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2014 | 301 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2014 | 588 | 0.110 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2014 | 116 | 0.110 |
Why?
|
Methylene Blue | 1 | 2013 | 155 | 0.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 567 | 0.110 |
Why?
|
Comorbidity | 5 | 2024 | 10388 | 0.110 |
Why?
|
Saliva | 1 | 2017 | 809 | 0.110 |
Why?
|
Food | 2 | 2015 | 772 | 0.110 |
Why?
|
Education, Dental | 1 | 2015 | 215 | 0.110 |
Why?
|
Eosinophilic Esophagitis | 1 | 2015 | 168 | 0.110 |
Why?
|
Natural Language Processing | 2 | 2017 | 1041 | 0.110 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3508 | 0.110 |
Why?
|
Enoxaparin | 1 | 2014 | 377 | 0.110 |
Why?
|
Intubation, Gastrointestinal | 1 | 2013 | 153 | 0.100 |
Why?
|
Coronary Angiography | 2 | 2014 | 4576 | 0.100 |
Why?
|
Stroke | 1 | 2014 | 9981 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2016 | 494 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2021 | 2259 | 0.100 |
Why?
|
Cooking | 1 | 2014 | 313 | 0.100 |
Why?
|
Disease Management | 2 | 2020 | 2460 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 77 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2013 | 302 | 0.100 |
Why?
|
Bacterial Toxins | 2 | 2015 | 931 | 0.100 |
Why?
|
Mannitol | 1 | 2012 | 181 | 0.100 |
Why?
|
Morpholines | 1 | 2014 | 571 | 0.100 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2016 | 789 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2013 | 11725 | 0.100 |
Why?
|
Obesity | 2 | 2022 | 12745 | 0.100 |
Why?
|
Immunomodulation | 1 | 2015 | 541 | 0.100 |
Why?
|
Genetic Markers | 2 | 2015 | 2634 | 0.100 |
Why?
|
Proteoglycans | 1 | 2014 | 836 | 0.100 |
Why?
|
Patient Readmission | 2 | 2015 | 3116 | 0.100 |
Why?
|
Analgesics | 1 | 2018 | 1040 | 0.090 |
Why?
|
Fetal Blood | 1 | 2017 | 1318 | 0.090 |
Why?
|
Boston | 4 | 2021 | 9312 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1076 | 0.090 |
Why?
|
Information Dissemination | 2 | 2017 | 1099 | 0.090 |
Why?
|
Employee Discipline | 1 | 1990 | 8 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1178 | 0.090 |
Why?
|
Professional Impairment | 1 | 1990 | 7 | 0.090 |
Why?
|
Students, Medical | 3 | 2015 | 1862 | 0.090 |
Why?
|
Problem-Based Learning | 3 | 2012 | 361 | 0.090 |
Why?
|
Patient Preference | 1 | 2018 | 889 | 0.090 |
Why?
|
Immunization | 1 | 2015 | 1256 | 0.090 |
Why?
|
Communication | 3 | 2014 | 3750 | 0.090 |
Why?
|
Plant Proteins | 1 | 2012 | 364 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2013 | 504 | 0.090 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2014 | 266 | 0.090 |
Why?
|
Prescription Drugs | 1 | 2017 | 595 | 0.090 |
Why?
|
Prognosis | 8 | 2016 | 29060 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 530 | 0.090 |
Why?
|
Thiophenes | 1 | 2014 | 589 | 0.090 |
Why?
|
Program Evaluation | 4 | 2015 | 2488 | 0.090 |
Why?
|
Pyridones | 1 | 2014 | 712 | 0.090 |
Why?
|
Europe | 3 | 2019 | 3339 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1655 | 0.090 |
Why?
|
Intention | 1 | 2012 | 342 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 738 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 547 | 0.090 |
Why?
|
Hypotension | 1 | 2016 | 884 | 0.090 |
Why?
|
Educational Status | 2 | 2015 | 2540 | 0.090 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2014 | 365 | 0.090 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1405 | 0.090 |
Why?
|
Histocompatibility Testing | 2 | 2014 | 741 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35424 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6171 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4153 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2014 | 850 | 0.090 |
Why?
|
Nanoparticles | 1 | 2021 | 1905 | 0.090 |
Why?
|
Databases, Factual | 2 | 2016 | 7730 | 0.090 |
Why?
|
Musculoskeletal Diseases | 1 | 2015 | 581 | 0.090 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 565 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4933 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 957 | 0.080 |
Why?
|
Risk Management | 1 | 2013 | 571 | 0.080 |
Why?
|
Fatigue | 1 | 2016 | 1531 | 0.080 |
Why?
|
Pathology | 1 | 2012 | 272 | 0.080 |
Why?
|
Parturition | 1 | 2012 | 441 | 0.080 |
Why?
|
Dehydration | 1 | 2010 | 233 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1837 | 0.080 |
Why?
|
Diet Surveys | 1 | 2012 | 1173 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4410 | 0.080 |
Why?
|
Secondary Prevention | 2 | 2012 | 1530 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2617 | 0.080 |
Why?
|
Thromboembolism | 1 | 2014 | 987 | 0.080 |
Why?
|
Qualitative Research | 1 | 2017 | 2682 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 880 | 0.080 |
Why?
|
Triage | 1 | 2015 | 977 | 0.080 |
Why?
|
Lymphoma | 1 | 2017 | 1877 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2017 | 4468 | 0.080 |
Why?
|
Incidence | 5 | 2018 | 20950 | 0.080 |
Why?
|
Curriculum | 3 | 2017 | 3605 | 0.080 |
Why?
|
Bronchoscopy | 1 | 2013 | 862 | 0.080 |
Why?
|
Propofol | 1 | 2013 | 629 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1637 | 0.070 |
Why?
|
International Classification of Diseases | 1 | 2013 | 867 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10943 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1253 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 3922 | 0.070 |
Why?
|
Appointments and Schedules | 1 | 2010 | 417 | 0.070 |
Why?
|
Risk | 2 | 2011 | 9688 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 1 | 2013 | 1133 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2455 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1066 | 0.070 |
Why?
|
Academic Medical Centers | 4 | 2019 | 2759 | 0.070 |
Why?
|
Bacteriological Techniques | 2 | 2018 | 277 | 0.070 |
Why?
|
Cultural Competency | 1 | 2009 | 289 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2019 | 15295 | 0.070 |
Why?
|
Warfarin | 1 | 2014 | 1497 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2575 | 0.070 |
Why?
|
Private Practice | 2 | 2017 | 154 | 0.070 |
Why?
|
Cultural Diversity | 1 | 2009 | 359 | 0.070 |
Why?
|
Bacteria | 1 | 2016 | 2115 | 0.070 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1641 | 0.070 |
Why?
|
Algorithms | 5 | 2023 | 13882 | 0.070 |
Why?
|
Education, Medical | 1 | 2017 | 1722 | 0.070 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 650 | 0.070 |
Why?
|
Bone Density | 2 | 2010 | 3468 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2625 | 0.060 |
Why?
|
Patients | 1 | 2012 | 900 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3283 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2052 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7914 | 0.060 |
Why?
|
Steroids | 1 | 2010 | 930 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1622 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12356 | 0.060 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2009 | 652 | 0.060 |
Why?
|
Bulimia | 1 | 2007 | 383 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2012 | 1547 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3279 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 1972 | 0.060 |
Why?
|
Treatment Failure | 2 | 2007 | 2618 | 0.060 |
Why?
|
Psychotropic Drugs | 1 | 1990 | 894 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1343 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13988 | 0.060 |
Why?
|
Child | 9 | 2023 | 77708 | 0.060 |
Why?
|
Societies, Medical | 4 | 2021 | 3743 | 0.060 |
Why?
|
Diet, Protein-Restricted | 1 | 2003 | 71 | 0.060 |
Why?
|
Phenotype | 3 | 2019 | 16367 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1739 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10183 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4216 | 0.060 |
Why?
|
Phyllodes Tumor | 1 | 2003 | 53 | 0.060 |
Why?
|
Self Report | 1 | 2014 | 3557 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2616 | 0.060 |
Why?
|
Contrast Media | 1 | 2016 | 5300 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2017 | 25041 | 0.050 |
Why?
|
Motivation | 1 | 2012 | 1971 | 0.050 |
Why?
|
Alleles | 1 | 2014 | 6933 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 12961 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6770 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12244 | 0.050 |
Why?
|
Community-Acquired Infections | 1 | 2006 | 465 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 19905 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2971 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3854 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2293 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2535 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5101 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2518 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2506 | 0.050 |
Why?
|
Glycolates | 1 | 2021 | 40 | 0.050 |
Why?
|
Registries | 3 | 2017 | 8091 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20130 | 0.050 |
Why?
|
Lymphoma, T-Cell | 1 | 2003 | 299 | 0.050 |
Why?
|
Virus Activation | 1 | 2003 | 319 | 0.050 |
Why?
|
Workload | 1 | 2017 | 849 | 0.050 |
Why?
|
Immunotherapy | 1 | 2016 | 4445 | 0.050 |
Why?
|
Internet | 1 | 2012 | 3064 | 0.050 |
Why?
|
Nurses | 1 | 1990 | 2462 | 0.050 |
Why?
|
Saccharomyces | 1 | 2020 | 65 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2795 | 0.040 |
Why?
|
Educational Measurement | 3 | 2015 | 1210 | 0.040 |
Why?
|
Tablets, Enteric-Coated | 1 | 2019 | 23 | 0.040 |
Why?
|
Micronutrients | 1 | 2022 | 375 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2003 | 513 | 0.040 |
Why?
|
Alcoholism | 1 | 1990 | 1906 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12952 | 0.040 |
Why?
|
Food Contamination | 1 | 2020 | 188 | 0.040 |
Why?
|
Intestine, Small | 2 | 2019 | 1240 | 0.040 |
Why?
|
Consensus | 2 | 2022 | 2960 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2645 | 0.040 |
Why?
|
Health Services Research | 2 | 2017 | 1836 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 17445 | 0.040 |
Why?
|
Animals | 5 | 2021 | 168770 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 967 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6254 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2015 | 13814 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.040 |
Why?
|
Anorexia Nervosa | 1 | 2007 | 1286 | 0.040 |
Why?
|
Child, Preschool | 3 | 2018 | 41005 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6539 | 0.040 |
Why?
|
Disclosure | 2 | 2014 | 736 | 0.040 |
Why?
|
Leadership | 1 | 2007 | 1357 | 0.040 |
Why?
|
Hepatitis B | 1 | 2003 | 695 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9145 | 0.040 |
Why?
|
Uncertainty | 1 | 2022 | 735 | 0.040 |
Why?
|
Research Design | 1 | 2012 | 5986 | 0.040 |
Why?
|
Gases | 1 | 2017 | 197 | 0.040 |
Why?
|
Bacterial Load | 1 | 2017 | 153 | 0.040 |
Why?
|
Gastroscopy | 1 | 2017 | 207 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3748 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2021 | 2274 | 0.030 |
Why?
|
Glucocorticoids | 2 | 2019 | 2108 | 0.030 |
Why?
|
Immunoassay | 1 | 2019 | 752 | 0.030 |
Why?
|
Hydrolysis | 1 | 2017 | 682 | 0.030 |
Why?
|
Folic Acid | 1 | 2022 | 1300 | 0.030 |
Why?
|
Hookworm Infections | 1 | 2015 | 13 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5749 | 0.030 |
Why?
|
Illinois | 1 | 2015 | 119 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6600 | 0.030 |
Why?
|
Sequence Homology | 1 | 2015 | 203 | 0.030 |
Why?
|
Hospitals | 1 | 2009 | 3954 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 441 | 0.030 |
Why?
|
Mass Screening | 1 | 2011 | 5255 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 454 | 0.030 |
Why?
|
Parotid Gland | 1 | 2015 | 168 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3527 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2019 | 2962 | 0.030 |
Why?
|
Primary Health Care | 1 | 2011 | 4557 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8479 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2065 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 793 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2017 | 368 | 0.030 |
Why?
|
Cross Reactions | 1 | 2015 | 841 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 1990 | 4257 | 0.030 |
Why?
|
Enterocytes | 1 | 2015 | 225 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1536 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2015 | 1095 | 0.030 |
Why?
|
Sweden | 1 | 2016 | 1346 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2017 | 954 | 0.030 |
Why?
|
Hordeum | 1 | 2012 | 20 | 0.030 |
Why?
|
Public Health Practice | 1 | 2015 | 218 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 1378 | 0.030 |
Why?
|
U937 Cells | 1 | 2012 | 268 | 0.030 |
Why?
|
Dermatitis Herpetiformis | 1 | 2012 | 26 | 0.030 |
Why?
|
Access to Information | 1 | 2015 | 320 | 0.030 |
Why?
|
Learning | 2 | 2015 | 1712 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2013 | 299 | 0.030 |
Why?
|
Diet | 1 | 2010 | 7937 | 0.030 |
Why?
|
Hematocrit | 1 | 2013 | 636 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 964 | 0.020 |
Why?
|
Self Efficacy | 1 | 2015 | 616 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 432 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1146 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 3914 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2017 | 1205 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2371 | 0.020 |
Why?
|
Metagenomics | 1 | 2014 | 428 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 18111 | 0.020 |
Why?
|
Nutritional Support | 1 | 2012 | 168 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 1005 | 0.020 |
Why?
|
Heart Failure | 1 | 2014 | 10895 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1730 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2029 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1656 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3130 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1410 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13104 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 551 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2571 | 0.020 |
Why?
|
Incidental Findings | 1 | 2014 | 689 | 0.020 |
Why?
|
Intestines | 1 | 2018 | 1924 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29144 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.020 |
Why?
|
Colitis | 1 | 2016 | 1170 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2839 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.020 |
Why?
|
Patient Admission | 1 | 2015 | 1380 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4251 | 0.020 |
Why?
|
Malpractice | 1 | 2013 | 572 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21693 | 0.020 |
Why?
|
Seasons | 1 | 2012 | 1493 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 934 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
Vaccines | 1 | 2015 | 823 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1316 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1880 | 0.020 |
Why?
|
Faculty | 1 | 2009 | 386 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 795 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1257 | 0.020 |
Why?
|
Family | 1 | 2016 | 3147 | 0.020 |
Why?
|
Endoscopy | 1 | 2015 | 1787 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1585 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12262 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1504 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15520 | 0.020 |
Why?
|
Infant | 2 | 2018 | 35134 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2726 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4208 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9735 | 0.010 |
Why?
|
Headache | 1 | 2011 | 1226 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3318 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2007 | 643 | 0.010 |
Why?
|
Mentors | 1 | 2007 | 631 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3589 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81202 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2531 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7323 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9957 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5755 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3224 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 16000 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1851 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 847 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14561 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12788 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18034 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9584 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 20823 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1990 | 2064 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21833 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23406 | 0.010 |
Why?
|
Liver | 1 | 2003 | 7475 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 9240 | 0.000 |
Why?
|